Femasys Inc

NASDAQ:FEMYUnited States

Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Contact Information

Headquarters

3950 JOHNS CREEK COURT, SUITE 100SUWANEE, GA, United States 30024

Phone

770-500-3910

Fax

---

Executives

Non-Executive Independent Chairman of the Board

Charles Larsen

President, Chief Executive Officer, Director

Kathy Lee-Sepsick

Chief Financial Officer

Dov Elefant

Chief Operating Officer, Senior Vice President

Daniel Currie

Senior Vice President - Regulatory and Clinical Affairs

Christine Thomas